Showing results (231-240 of 270) with videos related to
Sort By:
Pageof 27
Nature Communications|October 20, 2022
NIMA-related kinase 9 regulates the phosphorylation of the essential myosin light chain in the heartMarion Müller, Rose Eghbalian, Jes-Niels Boeckel, et al.Nature Communications|November 25, 2020
Common diseases alter the physiological age-related blood microRNA profileTobias Fehlmann, Benoit Lehallier, Nicholas Schaum, et al.Circulation|August 26, 2017
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart FailureBenjamin Meder, Jan Haas, Farbod Sedaghat-Hamedani, et al.Journal of the American College of Cardiology|August 19, 2017
Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo CardiomyopathyThomas Borchert, Daniela Hübscher, Celina I Guessoum, et al.The New England Journal of Medicine|March 18, 2026
Left Atrial Appendage Closure or Medical Therapy in Atrial FibrillationUlf Landmesser, Carsten Skurk, Paulus Kirchhof, et al.EMBO Molecular Medicine|November 16, 2017
Genomic structural variations lead to dysregulation of important coding and non-coding RNA species in dilated cardiomyopathyJan Haas, Stefan Mester, Alan Lai, et al.Circulation|March 25, 2024
Scrutinizing the Role of Venoarterial Extracorporeal Membrane Oxygenation: Has Clinical Practice Outpaced the Evidence?Enzo Lüsebrink, Leonhard Binzenhöfer, Daniel Hering, et al.EMBO Molecular Medicine|January 24, 2013
Alterations in cardiac DNA methylation in human dilated cardiomyopathyJan Haas, Karen S Frese, Yoon Jung Park, et al.Frontiers in Cardiovascular Medicine|March 29, 2024
A contemporary training concept in critical care cardiologyLeonhard Binzenhöfer, Nils Gade, Daniel Roden, et al.Journal of the American College of Cardiology|November 11, 2025
Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label TrialNeal K Lakdawala, Ray E Hershberger, Pablo Garcia-Pavia, et al.Pageof 27